Nauzene (Alva-Amco Pharmacal Companies, Inc.)


Welcome to the PulseAid listing for the Nauzene drug offered from Alva-Amco Pharmacal Companies, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Alva-Amco Pharmacal Companies, Inc.
NON-PROPRIETARY NAME: Sodium Citrate
SUBSTANCE NAME: TRISODIUM CITRATE DIHYDRATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2000-07-08
END MARKETING DATE: 0000-00-00


Nauzene HUMAN OTC DRUG Details:

Item DescriptionNauzene from Alva-Amco Pharmacal Companies, Inc.
LABELER NAME: Alva-Amco Pharmacal Companies, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 230(mg/1)
START MARKETING DATE: 2000-07-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52389-242_a271406b-1a71-4da1-92b0-86340fcf655e
PRODUCT NDC: 52389-242
APPLICATION NUMBER:

Other TRISODIUM CITRATE DIHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alva-Amco Pharmacal Companies, Inc.Nauzene
Citra Labs LLCtriCitrasol
Fenwal, Inc.Sodium Citrate Blood-Pack Units, (PL 146 Plastic)
Fresenius Kabi USA, LLCSodium Citrate Blood-Pack Units, (PL 146 Plastic)
Haemonetics CorporationHaemonetics Anticoagulant Sodium Citrate